Concordance and frequency of TP53 protein expression and gene sequence in mismatch repair proficient (pMMR) and POLE wild-type endometrial cancer: An endometrial cancer molecularly targeted therapy consortium (ECMT2) database study
Publication
, Conference
Vue, N; Miller, E; Secord, AA; Krivak, T; Crafton, S; Nakayama, J; Morse, C; Wield, A; Horne, Z; Zimmerman, J; Yin, Y; Linhart, S; Arend, R ...
Published in: Gynecologic Oncology
September 2025
Duke Scholars
Published In
Gynecologic Oncology
DOI
ISSN
0090-8258
Publication Date
September 2025
Volume
200
Start / End Page
S2 / S3
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Vue, N., Miller, E., Secord, A. A., Krivak, T., Crafton, S., Nakayama, J., … Hacker, K. (2025). Concordance and frequency of TP53 protein expression and gene sequence in mismatch repair proficient (pMMR) and POLE wild-type endometrial cancer: An endometrial cancer molecularly targeted therapy consortium (ECMT2) database study. In Gynecologic Oncology (Vol. 200, pp. S2–S3). Elsevier BV. https://doi.org/10.1016/j.ygyno.2025.04.522
Vue, Nujsaubnusi, Eirwen Miller, Angeles Alvarez Secord, Thomas Krivak, Sarah Crafton, John Nakayama, Christopher Morse, et al. “Concordance and frequency of TP53 protein expression and gene sequence in mismatch repair proficient (pMMR) and POLE wild-type endometrial cancer: An endometrial cancer molecularly targeted therapy consortium (ECMT2) database study.” In Gynecologic Oncology, 200:S2–3. Elsevier BV, 2025. https://doi.org/10.1016/j.ygyno.2025.04.522.
Vue N, Miller E, Secord AA, Krivak T, Crafton S, Nakayama J, et al. Concordance and frequency of TP53 protein expression and gene sequence in mismatch repair proficient (pMMR) and POLE wild-type endometrial cancer: An endometrial cancer molecularly targeted therapy consortium (ECMT2) database study. In: Gynecologic Oncology. Elsevier BV; 2025. p. S2–3.
Vue, Nujsaubnusi, et al. “Concordance and frequency of TP53 protein expression and gene sequence in mismatch repair proficient (pMMR) and POLE wild-type endometrial cancer: An endometrial cancer molecularly targeted therapy consortium (ECMT2) database study.” Gynecologic Oncology, vol. 200, Elsevier BV, 2025, pp. S2–3. Crossref, doi:10.1016/j.ygyno.2025.04.522.
Vue N, Miller E, Secord AA, Krivak T, Crafton S, Nakayama J, Morse C, Wield A, Horne Z, Zimmerman J, Yin Y, Linhart S, Arend R, Toboni M, Washington C, Cosgrove C, Haight P, Pothuri B, Hacker K. Concordance and frequency of TP53 protein expression and gene sequence in mismatch repair proficient (pMMR) and POLE wild-type endometrial cancer: An endometrial cancer molecularly targeted therapy consortium (ECMT2) database study. Gynecologic Oncology. Elsevier BV; 2025. p. S2–S3.
Published In
Gynecologic Oncology
DOI
ISSN
0090-8258
Publication Date
September 2025
Volume
200
Start / End Page
S2 / S3
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis